- Home
- ZDGE vs RLYB Comparison
ZDGE vs RLYB Comparison
Compare ZDGE & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- RLYB
- Stock Information
- Founded
- ZDGE 2008
- RLYB 2018
- Country
- ZDGE United States
- RLYB United States
- Employees
- ZDGE N/A
- RLYB N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- RLYB Health Care
- Exchange
- ZDGE Nasdaq
- RLYB Nasdaq
- Market Cap
- ZDGE 51.8M
- RLYB 46.1M
- IPO Year
- ZDGE N/A
- RLYB 2021
- Fundamental
- Price
- ZDGE $3.67
- RLYB $1.11
- Analyst Decision
- ZDGE
- RLYB Buy
- Analyst Count
- ZDGE 0
- RLYB 6
- Target Price
- ZDGE N/A
- RLYB $8.30
- AVG Volume (30 Days)
- ZDGE 47.1K
- RLYB 49.7K
- Earning Date
- ZDGE 10-24-2024
- RLYB 11-07-2024
- Dividend Yield
- ZDGE N/A
- RLYB N/A
- EPS Growth
- ZDGE N/A
- RLYB N/A
- EPS
- ZDGE N/A
- RLYB N/A
- Revenue
- ZDGE $29,142,000.00
- RLYB $299,000.00
- Revenue This Year
- ZDGE $13.67
- RLYB N/A
- Revenue Next Year
- ZDGE $13.41
- RLYB N/A
- P/E Ratio
- ZDGE N/A
- RLYB N/A
- Revenue Growth
- ZDGE 4.15
- RLYB N/A
- 52 Week Low
- ZDGE $1.70
- RLYB $1.08
- 52 Week High
- ZDGE $5.18
- RLYB $4.60
- Technical
- Relative Strength Index (RSI)
- ZDGE 61.16
- RLYB 47.41
- Support Level
- ZDGE $3.34
- RLYB $1.09
- Resistance Level
- ZDGE $3.75
- RLYB $1.18
- Average True Range (ATR)
- ZDGE 0.21
- RLYB 0.04
- MACD
- ZDGE 0.06
- RLYB 0.00
- Stochastic Oscillator
- ZDGE 88.68
- RLYB 22.22
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.